Chemical Compound

Butanedioic acid, 2-hydroxy-, (2S)-, compd. with 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-1,5,6,7- tetrahydro-3-methyl-4H-pyrrolo[3,2-c]pyridin-4-one (1:1);Butanedioic acid, 2-hydroxy-, (2S)-, compd. with 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-1,5,6,7- tetrahydro-3-methyl-4H-pyrrolo[3,2-c]pyridin-4-one (1:1)

CAS Registry Number 1044040-56-3
返回搜索 申请报价
Butanedioic acid, 2-hydroxy-, (2S)-, compd. with 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-1,5,6,7- tetrahydro-3-methyl-4H-pyrrolo[3,2-c]pyridin-4-one (1:1);Butanedioic acid, 2-hydroxy-, (2S)-, compd. with 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-1,5,6,7- tetrahydro-3-methyl-4H-pyrrolo[3,2-c]pyridin-4-one (1:1) 结构式
Primary record

Butanedioic acid, 2-hydroxy-, (2S)-, compd. with 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-1,5,6,7- tetrahydro-3-methyl-4H-pyrrolo[3,2-c]pyridin-4-one (1:1);Butanedioic acid, 2-hydroxy-, (2S)-, compd. with 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-1,5,6,7- tetrahydro-3-methyl-4H-pyrrolo[3,2-c]pyridin-4-one (1:1)

库存
3,035 克
纯度
99.1 %
CAS
1044040-56-3

化合物标识与属性

CAS
1044040-56-3
PubChem CID
16662431
SMILES
CCN(CC)CCN1CCC2=C(C1=O)C(=C(N2)/C=C\3/C4=C(C=CC(=C4)F)NC3=O)C
Canonical SMILES
CCN(CC)CCN1CCc2[nH]c(/C=C3\C(=O)Nc4ccc(F)cc43)c(C)c2C1=O

名称与同义词

  • Famitinib
  • Famitinib, (Z)
  • (Z)-Famitinib
  • Abit (China)
  • Famitinib (Standard)
  • SHR-1020
  • SHR1020
  • starbld0044024
  • FAMITINIB [INN]
  • 1044040-56-3
  • RefChem:139914
  • Famitinib (SHR1020)
  • D0Z6MT
  • UNII-768FW21J3L
  • FAMITINIB [WHO-DD]
  • 768FW21J3L
  • CHEMBL1278146
  • SCHEMBL137251
  • GTPL7886
  • orb1685248
  • DTXSID301358976
  • EX-A6762
  • SHR 1020
  • BDBM50331023
  • compound 9 [PMID: 21028894]
  • DB11741
  • HY-108713R
  • DA-63367
  • MS-27081
  • NS00072868
  • Receptor tyrosine kinase inhibitors (cancer)
  • J3.407.690A
  • G14485
  • 945380-27-8
  • A1009149
  • Q27077275
  • 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-3-methyl-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4-one
  • Tyrosine-kinase inhibitor (oral, cancer), Jiangsu Hengrui
  • Receptor tyrosine kinase inhibitors (cancer), Shanghai Hengrui
  • 4H-PYRROLO(3,2-C)PYRIDIN-4-ONE, 5-(2-(DIETHYLAMINO)ETHYL)-2-((5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL)-1,5,6,7-TETRAHYDRO-3-METHYL-
  • 5-(2-(diethylamino)ethyl0-2-9(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl)-3-methyl-6,7-dihydro-1H-pyrrolo(3,2-c)pyridin-4(5H)-one
  • C-Kit/VEGFR2/PDGFR/VEGFR3/Flt1/Flt3 inhibitor (oral, cancer), Jiangsu Hengrui
  • (3Z)-3-((5-(2-(diethylamino)ethyl)-3-methyl-4-oxo-1H,4H,5H,6H,7H-pyrrolo(3,2-c)pyridin-2-yl)methylidene)-5-fluoro-2,3-dihydro-1H-indol-2-one
  • (3Z)-3-({5-[2-(diethylamino)ethyl]-3-methyl-4-oxo-1H,4H,5H,6H,7H-pyrrolo[3,2-c]pyridin-2-yl}methylidene)-5-fluoro-2,3-dihydro-1H-indol-2-one
  • (Z)-2-(5-Fluoro-2-oxo-1,2-dihydroindol-3-ylidenemethyl)-5-(2-diethylaminoethyl)-3-methyl-1,5,6,7-tetrahydropyrrolo-[3,2-c]pyridin-4-one
  • (Z)-5-(2-(DIETHYLAMINO)ETHYL)-2-((5-FLUORO-2-OXOINDOLIN-3-YLIDENE)METHYL)-3-METHYL-6,7-DIHYDRO-1H-PYRROLO(3,2-C)PYRIDIN-4(5H)-ONE
  • (Z)-5-(2-(diethylamino)ethyl)-2-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-3-methyl-6,7-dihydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one
  • 4H-PYRROLO(3,2-C)PYRIDIN-4-ONE, 5-(2-(DIETHYLAMINO)ETHYL)-2-((Z)-(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL)-1,5,6,7-TETRAHYDRO-3-METHYL-
  • 5-(2-(Diethylamino)ethyl)-2-((5-fluoro-2-oxoindolin-3-ylidene)methyl)-3-methyl-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
  • 5-(2-(Diethylamino)ethyl)-2-((Z)-5-fluoro-2-oxoindoline-3-ylidene)methyl-3-methyl-6,7-dihydro-1H-pyrrolo[3,2-c]pyridine-4(5H)-one
  • 5-(2-diethylamino-ethyl)-2-(5-fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-3-methyl-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one
  • 5-(2-diethylaminoethyl)-2-((Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl)-3-methyl-6,7-dihydro-1H-pyrrolo(4,5-c)pyridin-4-one
  • 5-(2-diethylaminoethyl)-2-[(Z)-(5-fluoro-2-oxo-1H-indol-3-ylidene)methyl]-3-methyl-6,7-dihydro-1H-pyrrolo[4,5-c]pyridin-4-one
  • 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-3-methyl-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one
  • Butanedioic acid, 2-hydroxy-, (2S)-, compd. with 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-1,5,6,7- tetrahydro-3-methyl-4H-pyrrolo[3,2-c]pyridin-4-one (1:1);Butanedioic acid, 2-hydroxy-, (2S)-, compd. with 5-[2-(diethylamino)ethyl]-2-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-1,5,6,7- tetrahydro-3-methyl-4H-pyrrolo[3,2-c]pyridin-4-one (1:1)